Ciulla T A, Moulton R, Oberoi A, Miller J W
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
Curr Eye Res. 1995 Jul;14(7):573-8. doi: 10.3109/02713689508998404.
Previous animal models of central retinal artery occlusion using glass or latex embolic material may not simulate human disease. We have developed a rabbit model using human atherosclerotic material, which may be useful in developing embolus specific treatments, including thrombolysis or laser photodisruption. Fresh human atherosclerotic plaque was harvested from atherosclerotic human aorta by mechanical removal and suspension in normal saline. The suspension was agitated vigorously to produce small particles, which were separated into various sizes by filtration through mesh filters with specific pore sizes. The common carotid artery of the anesthetized rabbit was isolated by neck dissection and cannulated using a modified Seldinger technique. Suspensions of human atherosclerotic plaque were injected into the common carotid artery via this cannula. All animals were examined by slit lamp and fluorescein angiography before and after retinal artery occlusion. This model reliably produced retinal artery occlusion using human atherosclerotic plaque. Plaque particles less than 105 microns reliably produced branch retinal artery occlusion, while larger plaque particles less than 149 microns reliably produced central retinal artery occlusion. Sublingual nitroglycerin, at 0.1 mg/kg, intravenous verapamil, from 0.2 mg/kg to 2 mg/kg, and intracarotid urokinase given acutely in standard doses failed to cause reperfusion. This model will be very useful in the study and treatment of retinal vascular disorders as it may more closely simulate human disease over previous models using artificial embolic materials. Embolic specific treatment stategies, such as thrombolysis and laser photodisruption, may be further developed with this model.
以往使用玻璃或乳胶栓塞材料建立的视网膜中央动脉阻塞动物模型可能无法模拟人类疾病。我们利用人类动脉粥样硬化材料开发了一种兔模型,这可能有助于开发针对栓子的治疗方法,包括溶栓或激光光凝。通过机械切除从人类动脉粥样硬化主动脉中获取新鲜的动脉粥样硬化斑块,并悬浮于生理盐水中。剧烈搅拌悬浮液以产生小颗粒,通过具有特定孔径的筛网过滤器过滤将其分离成各种大小。通过颈部解剖分离麻醉兔的颈总动脉,并使用改良的Seldinger技术进行插管。通过该插管将人类动脉粥样硬化斑块悬浮液注入颈总动脉。在视网膜动脉阻塞前后,所有动物均通过裂隙灯和荧光素血管造影进行检查。该模型使用人类动脉粥样硬化斑块可靠地产生视网膜动脉阻塞。小于105微米的斑块颗粒可靠地产生视网膜分支动脉阻塞,而小于149微米的较大斑块颗粒可靠地产生视网膜中央动脉阻塞。0.1毫克/千克的舌下硝酸甘油、0.2毫克/千克至2毫克/千克的静脉维拉帕米以及标准剂量急性给予的颈动脉内尿激酶均未能引起再灌注。该模型在视网膜血管疾病的研究和治疗中将非常有用,因为与以往使用人工栓塞材料的模型相比,它可能更接近地模拟人类疾病。利用该模型可能会进一步开发针对栓子的治疗策略,如溶栓和激光光凝。